WallStSmart
GNPX

Genprex Inc

NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY

$0.98
+12.07% today

Updated 2026-04-30

Market cap
$8.41M
P/E ratio
P/S ratio
EPS (TTM)
$-17.40
Dividend yield
52W range
$1 – $55
Volume
1.1M

WallStSmart proprietary scores

23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.0
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$7.50
+669.23%
12-Month target
$4.25
+335.90%
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-4.10M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-23.74M$-30.86M$-21.11M$-16.23M$-3.79M
EPS$-17.40
Free cash flow$-17.78M$-24.81M$-17.15M$-15.31M$-4.10M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
GNPX$8.41M234.33.05.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Genprex Inc trades at $0.98. Our Smart Value Score of 23/100 indicates the stock is weak.

Frequently asked questions

What is Genprex Inc's stock price?
Genprex Inc (GNPX) trades at $0.98.
Is Genprex Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Genprex Inc (GNPX)?
The analyst target price is $7.50, representing +669.2% upside from the current price of $0.98.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-338.70%
Beta-0.67
50D MA$1.70
200D MA$6.00
Shares out0.01B
Float0.01B
Short ratio
Avg volume1.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years